Brady Martz Wealth Solutions LLC Purchases New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brady Martz Wealth Solutions LLC acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,028 shares of the medical equipment provider’s stock, valued at approximately $554,000.

Other hedge funds also recently modified their holdings of the company. Intech Investment Management LLC grew its stake in shares of Intuitive Surgical by 6.2% in the 2nd quarter. Intech Investment Management LLC now owns 21,279 shares of the medical equipment provider’s stock worth $9,466,000 after acquiring an additional 1,244 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its holdings in Intuitive Surgical by 5.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 6,450 shares of the medical equipment provider’s stock worth $2,870,000 after purchasing an additional 338 shares during the last quarter. King Luther Capital Management Corp increased its stake in Intuitive Surgical by 2.1% in the 2nd quarter. King Luther Capital Management Corp now owns 5,670 shares of the medical equipment provider’s stock valued at $2,522,000 after buying an additional 114 shares during the last quarter. AE Wealth Management LLC increased its stake in Intuitive Surgical by 24.5% in the 2nd quarter. AE Wealth Management LLC now owns 3,822 shares of the medical equipment provider’s stock valued at $1,700,000 after buying an additional 752 shares during the last quarter. Finally, Sei Investments Co. lifted its position in shares of Intuitive Surgical by 1.4% during the 2nd quarter. Sei Investments Co. now owns 527,686 shares of the medical equipment provider’s stock worth $234,734,000 after buying an additional 7,080 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on ISRG. Raymond James increased their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Truist Financial boosted their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares of the company’s stock, valued at $140,595. The trade was a 88.63 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,190 shares of company stock worth $25,012,927. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $592.64 on Friday. The stock has a market cap of $211.09 billion, a P/E ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68. The firm’s fifty day moving average price is $540.66 and its 200-day moving average price is $498.77.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.